Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3091 to 3105 of 8911 results

  1. Gender pay gap report

    Information about NICE's gender pay gap data for the 12 months leading up to 31 March 2025.

  2. Public board meeting agenda and papers: March 2022

    Agenda and papers of the NICE public board meeting on 17 March 2022

  3. EDI roadmap and annual action plan

    NICE's equality, diversity, and inclusion roadmap and annual action plan - committed to creating a forward-looking, positive work culture where everyone can thrive.

  4. Public board meeting agenda and papers: May 2024

    Agenda and papers of the NICE public board meeting on 15 May 2024

  5. Public board meeting agenda and papers: May 2023

    Agenda and papers of the NICE public board meeting on 17 May 2023

  6. Public board meeting agenda and papers: May 2022

    Agenda and papers of the NICE public board meeting on 25 May 2022

  7. Public board meeting agenda and papers: July 2024

    Agenda and papers of the NICE public board meeting on 17 July 2024

  8. Public board meeting agenda and papers: July 2023

    Agenda and papers of the NICE public board meeting on 19 July 2023

  9. Public board meeting agenda and papers: July 2022

    Agenda and papers of the NICE public board meeting on 22 July

  10. Public board meeting agenda and papers: September 2024

    Agenda and papers of the NICE public board meeting on 25 September 2024

  11. Public board meeting agenda and papers: September 2023

    Agenda and papers of the NICE public board meeting on 21 September 2023

  12. Public board meeting agenda and papers: September 2022

    Agenda and papers of the NICE public board meeting on 22 September

  13. About us

    NICE helps practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.

  14. Research to access pathway for investigational drugs for COVID-19 (RAPID C-19)

    RAPID C-19’s role in reviewing potential COVID-19 treatments has now ended because we have moved back to routine commissioning arrangements for these treatments.

  15. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation.